Literature DB >> 8154933

Abnormal haem biosynthesis in the chronic anaemia of rheumatoid arthritis.

T Houston1, M Moore, D Porter, R Sturrock, E Fitzsimons.   

Abstract

OBJECTIVES: The chronic microcytic anaemia of rheumatoid arthritis (RA) occurs despite the presence of adequate reticulo-endothelial iron stores. The red cell microcytosis is evidence of impaired haemoglobin production. This study has examined possible abnormalities of erythroid haem biosynthesis that may contribute to the anaemia.
METHODS: 5-Aminolaevulinate (ALA) synthase and ferrochelatase activities were assayed in whole bone marrow and in purified erythroblasts from patients with RA and in control subjects. All patients were iron replete with demonstrable iron in the bone marrow.
RESULTS: ALA synthase activity was significantly reduced in both whole bone marrow and purified erythroblasts from patients with the anaemia of RA. Erythrocyte protoporphyrin levels were raised in nine of 12 patients tested while ferrochelatase activity was normal.
CONCLUSION: These abnormalities provide absolute evidence of abnormal erythroblast haem biosynthesis and iron metabolism in the anaemia of RA and most likely reflect decreased ALA synthase mRNA translation and some abnormality of erythroblast iron transport. Further studies using highly purified erythroblast populations will attempt to identify the causal factors leading to this abnormal erythroblast metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8154933      PMCID: PMC1005280          DOI: 10.1136/ard.53.3.167

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

Review 1.  Haem synthesis and iron uptake by reticulocytes.

Authors:  P Ponka; J Neuwirt
Journal:  Br J Haematol       Date:  1974-09       Impact factor: 6.998

2.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

3.  Erythropoiesis in the anaemia of chronic disease.

Authors:  I Cavill; C Ricketts; J A Napier
Journal:  Scand J Haematol       Date:  1977-11

4.  The role of haem biosynthetic and degradative enzymes in erythroid colony development: the effect of haemin.

Authors:  N G Ibrahim; J D Lutton; R D Levere
Journal:  Br J Haematol       Date:  1982-01       Impact factor: 6.998

Review 5.  Sideroblastic anaemia.

Authors:  S S Bottomley
Journal:  Clin Haematol       Date:  1982-06

6.  Crystallization and characterization of a new protease in mitochondria of bone marrow cells.

Authors:  Y Aoki
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

7.  Isolation of human haematopoietic progenitor cells using monoclonal antibodies.

Authors:  P C Beverley; D Linch; D Delia
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

8.  Erythropoiesis in the anaemia of rheumatoid arthritis.

Authors:  I Cavill; D P Bentley
Journal:  Br J Haematol       Date:  1982-04       Impact factor: 6.998

9.  Hemin control of heme biosynthesis in mouse Friend virus-transformed erythroleukemia cells in culture.

Authors:  J L Granick; S Sassa
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

10.  The involvement of lactoferrin in the hyposideremia of acute inflammation.

Authors:  J L Van Snick; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  3 in total

1.  Conversion of 5-aminolevulinate synthase into a more active enzyme by linking the two subunits: spectroscopic and kinetic properties.

Authors:  Junshun Zhang; Anton V Cheltsov; Gloria C Ferreira
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

Review 2.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

3.  The immunometabolite itaconate inhibits heme synthesis and remodels cellular metabolism in erythroid precursors.

Authors:  Jason R Marcero; James E Cox; Hector A Bergonia; Amy E Medlock; John D Phillips; Harry A Dailey
Journal:  Blood Adv       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.